CFTC Orders Kalshi to Stay Live in New York
Federal regulator overrides state lawsuit, forcing a showdown on prediction market jurisdiction.
The CFTC ordered Kalshi to keep its sports-related prediction markets running in New York, directly overriding a state lawsuit filed last month that sought to shut them down.
Why It Matters
Federal preemption of state gambling law is the core issue here, and the CFTC's directive signals that it views Kalshi's event contracts as regulated commodity instruments — not sports betting subject to state oversight. For operators and investors watching the prediction-market space, this sets a precedent: a federally licensed exchange may be able to run sports event contracts in states that would otherwise ban them. That tension between federal commodity law and state gambling statutes is unresolved, and the outcome of this dispute will shape how platforms like Kalshi, Polymarket, and potential entrants structure their U.S. offerings. Gambling involves real financial risk, and users in contested jurisdictions should monitor the legal status of any platform they use.
Context
New York sued Kalshi as of July 2026, arguing its sports-related contracts constituted illegal sports wagering under state law. Kalshi operates as a CFTC-regulated designated contract market (DCM), a status it has used to argue federal jurisdiction supersedes state gambling prohibitions — a legal theory previously tested during Kalshi's earlier fight with the CFTC itself. The CFTC's intervention, directing Kalshi to continue operations, suggests the agency is prepared to defend that federal boundary actively.
What's Next
New York must now decide whether to escalate the lawsuit through federal courts, where the preemption argument will face direct scrutiny. A ruling on the merits could either cement federal authority over event contracts nationwide or hand individual states a path to restrict them.
Related on WeeBet
Keep reading
WeeBet Weekly
The week's biggest market move, in 4 minutes.
Every Friday: the top Polymarket and Kalshi price shift, one regulatory story that actually matters, and one chart. No fluff, no promo. Free.
Free. Unsubscribe in one click. We'll never sell your email.